ASCO 2023: Focus on Breast Cancer
Real-world outcomes were comparable to clinical trials in breast cancers with BRCA mutations treated with PARP inhibitors. A cohort analysis found abbreviated breast MRI was an effective for cancer screening in patients with dense breasts. Patients with DCIS breast cancer had "excellent disease control" after lumpectomy and accelerated partial breast irradiation. Results from the 21-gene Breast Recurrence Score commercial assay were successful predictors for cancer-specific mortality.